Ticker > Company >

Vineet Laboratories share price

Vineet Laboratories Ltd.

NSE: VINEETLAB BSE: 543298 SECTOR: Pharmaceuticals & Drugs  20.27 K   20   3

33.52
+0.01 (0.03%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 33.52

Today's Low

₹ 33.52

52 Week High

₹ 65.85

52 Week Low

₹ 25.35

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

30.9 Cr.

Enterprise Value

74.76 Cr.

No. of Shares

0.92 Cr.

P/E

0

P/B

2.24

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  14.99

CASH

0.44 Cr.

DEBT

44.3 Cr.

Promoter Holding

29.26 %

EPS (TTM)

₹  -20.53

Sales Growth

-29.06%

ROE

3 %

ROCE

7.16%

Profit Growth

-18 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-29.06%
3 Year-14.8%
5 Year∞%

Profit Growth

1 Year-18%
3 Year-20%
5 Year∞%

ROE%

1 Year3%
3 Year9.65%
5 Year7.85%

ROCE %

1 Year7.16%
3 Year12.99%
5 Year14.03%

Debt/Equity

1.2758

Price to Cash Flow

-2.7

Interest Cover Ratio

1.076

CFO/PAT (5 Yr. Avg.)

1.31666616139869

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 29.26 0.00
Mar 2025 35.85 0.00
Dec 2024 35.85 0.00
Sep 2024 36.07 0.00
Jun 2024 37.50 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.0907373821763046.
  • The company has an efficient Cash Conversion Cycle of 89.1526 days.

 Limitations

  • The company has shown a poor profit growth of -16.7521206517559% for the Past 3 years.
  • The company has shown a poor revenue growth of -14.7985708986506% for the Past 3 years.
  • Company has negative cash flow from operations of -11.4272.
  • The company has a low EBITDA margin of 3.72392969456145% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 23.86 18.96 18.1 14.08 7.44
Total Expenditure 24.66 19.26 22.24 25.12 7.12
Operating Profit -0.79 -0.31 -4.14 -11.05 0.32
Other Income 0.37 0.2 0.03 1.38 0.02
Interest 1.14 0.99 0.95 0.9 0.61
Depreciation 0.61 0.62 0.62 0.66 0.63
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.17 -1.71 -5.67 -11.22 -0.9
Tax -0.04 0.12 0.03 -0.7 -0.04
Profit After Tax -2.13 -1.83 -5.71 -10.53 -0.87
Adjusted EPS (Rs) -2.31 -1.98 -6.19 -11.42 -0.94

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 243.48 191.17 212.29 150.59
Total Expenditure 0.01 235.33 178.01 204.63 143.39
Operating Profit -0.01 8.15 13.16 7.66 7.2
Other Income 0 0.39 0.29 0.12 0.46
Interest 0 2.67 2.09 3.38 4.78
Depreciation 0 1.81 2.02 2.37 2.52
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.01 4.06 9.35 2.03 0.36
Tax 0 2.28 2.71 0.78 -0.66
Net Profit -0.01 2.01 6.6 1.25 1.03
Adjusted EPS (Rs.) -0.27 1.93 7.2 1.36 1.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.41 9.22 9.22 9.22 9.22
Total Reserves -0.01 17.4 24 24.46 25.51
Borrowings 0 3.47 1.72 4.85 3.89
Other N/C liabilities 0 4.01 3.61 2.81 2.27
Current liabilities 0 74.65 94.77 74.51 76
Total Liabilities 0.4 108.74 133.32 115.85 116.87
Assets
Net Block 0 19.67 21.38 26.65 26.92
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0.12 0.14 0.13 0.18
Loans & Advances 0 2.52 9.09 1.61 1.59
Other N/C Assets 0 0.08 0 0 0
Current Assets 0.4 86.36 102.7 87.46 88.19
Total Assets 0.4 108.74 133.32 115.85 116.87
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.01 4.06 9.35 2.03 0.36
Adjustment 0 5.71 3.9 5.97 1.97
Changes in Assets & Liabilities 0.01 16.87 -2.43 -14.63 -13.5
Tax Paid 0 0.85 -3.18 -2.99 -0.25
Operating Cash Flow 0 27.49 7.63 -9.62 -11.43
Investing Cash Flow 0 -7.81 -3.68 -6.69 0.33
Financing Cash Flow 0 18.62 11.96 0.27 10.69
Net Cash Flow 0 38.3 15.91 -16.03 -0.4

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 37.50 36.07 35.85 35.85 29.26
a prabhakar raju 3.87 3.87 3.87 3.87 2.96
a ranga raju 2.08 2.08 2.08 2.08 1.54
a srinivasa raju 2.77 2.77 2.77 2.77 1.68
alluri anantha laxmi 1.80 1.80 1.80 1.80 1.32
alluri mythili - - - - 1.68
gaddam balaji 0.18 0.18 0.18 0.18 0.01
gaddam srinivasarao 0.39 0.39 0.39 0.39 0.39
gaddam venkata rama - - - - 4.12
gaddam venkata ramana - - - - 9.01
kandula murali mohan - - - 0.01 0.01
p kishore raju 0.81 0.81 0.81 0.81 0.81
penmetsa venkata krishnam... 0.93 0.93 0.93 0.93 0.93
satyanarayana raju bhupat... 5.63 5.63 5.63 5.63 4.61
v varaprasada rao 1.32 0.42 0.20 0.20 0.19
alluri maithili 2.22 2.22 2.22 2.22 -
venkata rama gaddam 5.94 5.94 5.94 5.94 -
venkata ramana gaddam 9.01 9.01 9.01 9.01 -
murali mohan kandula 0.54 0.01 0.01 - -
a ranga raju 2.08 2.08 2.08 2.08 1.54
alluri anantha laxmi 1.80 1.80 1.80 1.80 1.32
gaddam balaji 0.18 0.18 0.18 0.18 0.01
p kishore raju 0.81 0.81 0.81 0.81 0.81
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 62.50 63.93 64.15 64.15 70.74
dheeraj kumar lohia 1.71 1.71 1.50 1.28 1.22
rajesh poddar 4.48 4.48 4.48 4.48 4.48
seetaramanjaneyulu n - - - - 1.04
surekha naga lakshmi pend... - - - - 4.34
vineet laboratories ltd -... - - 1.02 1.02 1.02
wessel consultancy privat... - - - 1.80 -
chaubara eats private lim... - - 1.80 - -
shabbir nazmuddin paratha... 2.25 2.06 1.59 - -
aparna devi manthena 1.01 - - - -
vineet laboratories ltd 1.02 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us

Vineet Laboratories Stock Price Analysis and Quick Research Report. Is Vineet Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vineet Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vineet Laboratories has a PE ratio of -1.65146732140769 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vineet Laboratories has ROA of 0.8827% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vineet Laboratories has a Current ratio of 1.1604.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vineet Laboratories has a ROE of 3.0029%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vineet Laboratories has a Debt to Equity ratio of 1.2758 which means that the company has low proportion of debt in its capital.

  • Sales growth: Vineet Laboratories has reported revenue growth of -29.0645% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vineet Laboratories for the current financial year is 4.78128550586919%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vineet Laboratories is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vineet Laboratories is Rs -20.5272. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vineet Laboratories in Ticker for free. Also, one can get the intrinsic value of Vineet Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vineet Laboratories FAQs

Q1. What is Vineet Laboratories share price today?
Ans: The current share price of Vineet Laboratories is Rs 33.9.

Q2. What is the market capitalisation of Vineet Laboratories?
Ans: Vineet Laboratories has a market capitalisation of Rs 31.25243712 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vineet Laboratories?
Ans: The PE ratio of Vineet Laboratories is -1.65146732140769 and the P/B ratio of Vineet Laboratories is 2.26138698401686, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vineet Laboratories share?
Ans: The 52-week high share price of Vineet Laboratories is Rs 64.69, and the 52-week low share price of Vineet Laboratories is Rs 26.51.

Q5. Does Vineet Laboratories pay dividends?
Ans: Currently, Vineet Laboratories does not pay dividends. Dividend yield of Vineet Laboratories is around 0%.

Q6. What are the face value and book value of Vineet Laboratories shares?
Ans: The face value of Vineet Laboratories shares is Rs 10, while the book value per share of Vineet Laboratories is around Rs 14.9908. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vineet Laboratories?
Ans: Vineet Laboratories has a total debt of Rs 44.2996 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vineet Laboratories?
Ans: The ROE of Vineet Laboratories is 3.0029% and ROCE of Vineet Laboratories is 7.1551%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vineet Laboratories a good buy for the long term?
Ans: The Vineet Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vineet Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vineet Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vineet Laboratories’s financials?
Ans: You can review Vineet Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Vineet Laboratories
X